Mi az a Famvir (Famciclovir)?
Famvir (famciclovir) is an oral antiviral prescription medicine approved by the European Medicines Agency (EMA) for the treatment of infections caused by herpes simplex virus (HSV-1 and HSV-2) and varicella-zoster virus (VZV). In the context of sexual health, it is used to treat genital herpes outbreaks and as suppressive therapy to reduce recurrence and transmission risk.
Famciclovir is a prodrug — it is converted in the body to its active form, penciclovir, which exerts the antiviral effect. It is well established in clinical practice alongside valacyclovir (Valtrex) and aciclovir (Zovirax) as one of the three main antiviral options for herpes infections.
Hogyan hat a Famvir (Famciclovir)?
After oral administration, famciclovir undergoes rapid first-pass metabolism to penciclovir, its active antiviral metabolite.
The mechanism proceeds as follows:
- Viral thymidine kinase phosphorylation: Penciclovir enters cells infected with herpes virus. The viral enzyme thymidine kinase (TK) — present in infected cells but not in uninfected human cells — phosphorylates penciclovir to penciclovir monophosphate.
- Further phosphorylation: Cellular kinases convert penciclovir monophosphate to penciclovir triphosphate, the active form.
- DNA polymerase inhibition: Penciclovir triphosphate competitively inhibits the viral DNA polymerase, the enzyme responsible for replicating viral DNA, preventing the virus from reproducing.
- Selective activity: Because viral TK selectively activates penciclovir in infected cells, the drug’s antiviral effect is concentrated where the virus is active, limiting effects on normal cells.
Key pharmacokinetic feature: Penciclovir has a long intracellular half-life (7–20 hours in HSV-infected cells), which may allow for less frequent dosing compared to aciclovir.
Kinek ajánlott a Famvir (Famciclovir)?
Famvir is indicated for adults with herpes simplex and herpes zoster infections:
Sexual health indications:
- First episode of genital herpes (HSV-1 or HSV-2): Reduces severity and duration of the initial episode
- Recurrent genital herpes: Episodic treatment to shorten outbreak duration when started early
- Suppressive therapy: Continuous daily treatment to reduce frequency of recurrent outbreaks and reduce transmission to sexual partners
- Orolabial herpes (cold sores): Treatment and suppression
Other indications:
- Herpes zoster (shingles): Reduces duration and severity of acute shingles and post-herpetic neuralgia when started within 72 hours of rash onset
- Herpes zoster ophthalmicus: Shingles affecting the eye area — under specialist supervision
Famvir is not effective against:
- HIV and other retroviruses
- Bacterial, fungal, or other infections
- HPV (genital warts, cervical infection)
Adagolás
| Indication | Dose | Duration |
|---|---|---|
| First episode genital herpes | 250 mg three times daily | 5–10 days |
| Recurrent genital herpes (episodic) | 125 mg twice daily | 5 days |
| Recurrent genital herpes (single day) | 1000 mg twice daily | 1 day |
| Suppressive therapy | 250 mg twice daily | Ongoing (review annually) |
| Cold sores (orolabial herpes) | 1500 mg single dose | 1 day |
| Shingles (herpes zoster) | 500 mg three times daily | 7 days |
Important: Dose reduction is required in patients with reduced kidney function (renal impairment). A doctor will calculate the appropriate dose based on kidney function test results.
Famvir tablets can be taken with or without food.
Mellékhatások
Famvir is generally well tolerated. Side effects are similar to other oral antiviral medicines used for herpes.
Gyakori mellékhatások (100 személyből 1-10-nél)
- Headache
- Nausea
- Diarrhoea
- Dizziness
- Fatigue
Less common side effects
- Abdominal pain
- Vomiting
- Pruritus (itching)
- Rash
Rare but serious side effects
- Severe allergic reactions: Including anaphylaxis — seek immediate medical help if facial swelling, breathing difficulty, or collapse occurs
- Neurological effects: Confusion, hallucinations, and agitation — more common in elderly patients or those with renal impairment; stop treatment and seek urgent medical attention
- Haematological effects: Thrombocytopenia (low platelet count) — rare with standard doses
- Renal impairment: Adequate hydration is important; dose reduction is required in pre-existing renal impairment
Famvir (Famciclovir) vs alternatívák
| Medicine | Active Ingredient | Dosing (episodic) | Dosing (suppressive) |
|---|---|---|---|
| Famvir | Famciclovir | 125 mg twice daily (5 days) | 250 mg twice daily |
| Valtrex | Valacyclovir | 500 mg twice daily (3–5 days) | 500 mg once daily |
| Zovirax | Aciclovir | 200 mg 5 times daily (5 days) | 400 mg twice daily |
Clinical equivalence: All three antiviral options (famciclovir, valacyclovir, aciclovir) have similar clinical efficacy for treating herpes simplex and zoster infections. The choice is typically based on dosing frequency, patient preference, and cost.
- Famvir vs Valtrex: Both are prodrugs with similar efficacy and tolerability. Valacyclovir may offer slightly more convenient dosing for some indications.
- Famvir vs Zovirax: Aciclovir requires five doses per day for episodic treatment, making it less convenient than famciclovir or valacyclovir. However, aciclovir is often less expensive.
Hogyan szerezhető be a Famvir (Famciclovir) online Európában
Famvir vényköteles gyógyszer az EU összes tagállamában. Nem adható ki jogszerűen érvényes orvosi rendelvény nélkül.
A Prescrivia technológiai közvetítőként működik: nem írunk fel gyógyszereket, nem alkalmazunk orvosokat és nem értékesítünk gyógyszereket. Platformunk pácienseket kapcsol össze független, EU-ban regisztrált orvosokkal, akik bizalmas online egészségügyi felméréseket végezhetnek.
A folyamat a következő:
- Töltse ki az egészségügyi kérdőívet: Describe your symptoms, history of herpes episodes, and any current medications or kidney problems.
- Orvosi felülvizsgálat: An independent EU-registered doctor reviews your assessment. If famciclovir is clinically appropriate, they may issue a prescription.
- Recept és teljesítés: The prescription is sent to a licensed EU pharmacy partner for dispensing and direct delivery.
Important: Prescrivia does not guarantee that a prescription will be issued. All prescribing decisions are made independently by qualified medical professionals.
Fontos biztonsági tudnivalók
Tell your doctor before taking Famvir if you:
- Have kidney disease (dose adjustment is required)
- Are pregnant or breastfeeding (limited data — a doctor must assess risk-benefit)
- Are immunocompromised (HIV, transplant medication, cancer treatment)
- Are elderly (increased risk of neurological side effects at higher doses)
- Are taking any other medicines, particularly those affecting kidney function
Transmission reduction: Suppressive antiviral therapy reduces (but does not eliminate) the risk of transmitting genital herpes to sexual partners. Consistent use of condoms provides additional risk reduction. Partners should be informed of herpes status to make informed decisions.
Resistance: Antiviral resistance to famciclovir/penciclovir is uncommon in immunocompetent individuals but may occur in immunocompromised patients on long-term therapy. A doctor should be consulted if treatment appears to be losing effectiveness.
Források
Az oldalon található orvosi információk az alábbi forrásokon alapulnak:
- European Medicines Agency (EMA). Famvir (famciclovir) — Summary of Product Characteristics. Available at: ema.europa.eu
- World Health Organization (WHO). Herpes simplex virus — Fact sheet. who.int
- Gupta R, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. Journal of Infectious Diseases. 2004.
- Bodsworth NJ, et al. Famciclovir in the treatment of genital herpes. Antiviral Research. 1997.
Ez a tartalom rendszeresen felülvizsgálatra kerül a frissített klinikai irányelvek tükrözése érdekében. Kizárólag tájékoztató jelleggel készült, és nem minősül orvosi tanácsadásnak. Mindig konzultáljon képzett egészségügyi szakemberrel az Ön egyéni egészségügyi körülményeire vonatkozó tanácsért.
Frequently asked questions
- Mire használják a Famvir (Famciclovir)?
- Famvir (famciclovir) is an antiviral medicine approved by the EMA for the treatment of genital herpes (herpes simplex virus type 1 and 2), cold sores (orolabial herpes), and herpes zoster (shingles). It is used both for treating active outbreaks and, at lower doses, as suppressive therapy to reduce the frequency of recurrent herpes episodes.
- How does Famvir differ from Valtrex and Zovirax?
- All three medicines (famciclovir, valacyclovir, aciclovir) ultimately inhibit the same viral enzyme (thymidine kinase and DNA polymerase) and have similar clinical efficacy for herpes infections. Famvir is a prodrug of penciclovir, while Valtrex is a prodrug of aciclovir. Famvir may have a longer intracellular half-life and requires less frequent dosing for some indications. The choice between them is typically based on patient preference, dosing convenience, and cost.
- Mennyi ideig does a Famvir course last for genital herpes?
- For a first episode of genital herpes, famciclovir is typically taken three times daily for 5 to 10 days. For recurrent episodes treated early (ideally within 24–48 hours of symptom onset), a shorter 3 to 5-day course or single-day high-dose regimen may be used. For suppressive therapy, famciclovir is taken twice daily continuously.
- Does Famvir cure herpes?
- No antiviral medicine currently cures herpes simplex virus infection. Herpes simplex virus establishes lifelong latency in nerve cells and cannot be fully eliminated with current treatments. Famvir and other antivirals suppress viral replication, reduce the severity and duration of outbreaks, and with suppressive therapy, reduce transmission risk. All clinical decisions are made by independent doctors.
- Megkaphatom a Famvir (Famciclovir) készítményt online Európában?
- A készítményhez online közvetítő platformokon keresztül férhet hozzá, amelyek független, EU-ban regisztrált orvosokkal kötik össze Önt. A bizalmas egészségügyi kérdőív kitöltése után az orvos felméri, hogy a gyógyszer klinikailag megfelelő-e az Ön számára.
A Prescrivia közvetítő platform. Nem nyújtunk orvosi szolgáltatásokat, nem írunk fel kezeléseket és nem adunk ki gyógyszereket. Minden orvosi döntést független, EU-ban regisztrált orvosok hoznak. Minden gyógyszert engedéllyel rendelkező EU-gyógyszertárak adnak ki. Ez a platform összeköti a betegeket és az egészségügyi szolgáltatókat.